Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Design of Therapeutic Self-Assembled Monolayers of Thiolated Abiraterone.

Stolarczyk EU, Sidoryk K, Cybulski M, Kubiszewski M, Stolarczyk K.

Nanomaterials (Basel). 2018 Dec 7;8(12). pii: E1018. doi: 10.3390/nano8121018.

2.

Design and Molecular Modeling of Abiraterone-Functionalized Gold Nanoparticles.

Stolarczyk EU, Łaszcz M, Leś A, Kubiszewski M, Kuziak K, Sidoryk K, Stolarczyk K.

Nanomaterials (Basel). 2018 Aug 22;8(9). pii: E641. doi: 10.3390/nano8090641.

3.

Use of the hyphenated LC-MS/MS technique and NMR/IR spectroscopy for the identification of exemestane stress degradation products during the drug development.

Stolarczyk EU, Rosa A, Kubiszewski M, Zagrodzka J, Cybulski M, Kaczmarek Ł.

Eur J Pharm Sci. 2017 Nov 15;109:389-401. doi: 10.1016/j.ejps.2017.08.033. Epub 2017 Sep 1.

PMID:
28865686
4.

Pemetrexed conjugated with gold nanoparticles - Synthesis, characterization and a study of noncovalent interactions.

Stolarczyk EU, Stolarczyk K, Łaszcz M, Kubiszewski M, Leś A, Michalak O.

Eur J Pharm Sci. 2017 Nov 15;109:13-20. doi: 10.1016/j.ejps.2017.07.011. Epub 2017 Jul 12.

5.

Synthesis and characterization of genistein conjugated with gold nanoparticles and the study of their cytotoxic properties.

Stolarczyk EU, Stolarczyk K, Łaszcz M, Kubiszewski M, Maruszak W, Olejarz W, Bryk D.

Eur J Pharm Sci. 2017 Jan 1;96:176-185. doi: 10.1016/j.ejps.2016.09.019. Epub 2016 Sep 16.

PMID:
27644892
6.

Identification and physicochemical characteristics of temozolomide process-related impurities.

Łaszcz M, Kubiszewski M, Jedynak L, Kaczmarska M, Kaczmarek Ł, Łuniewski W, Gabarski K, Witkowska A, Kuziak K, Malińska M.

Molecules. 2013 Dec 11;18(12):15344-56. doi: 10.3390/molecules181215344.

7.

Physicochemical characteristics of sunitinib malate and its process-related impurities.

Sidoryk K, Malińska M, Bańkowski K, Kubiszewski M, Łaszcz M, Bodziachowska-Panfil M, Kossykowska M, Giller T, Kutner A, Woźniak K.

J Pharm Sci. 2013 Feb;102(2):706-16. doi: 10.1002/jps.23412. Epub 2012 Dec 11.

PMID:
23233239
8.

Stability studies and structural characterization of pramipexole.

Łaszcz M, Trzcińska K, Kubiszewski M, Kosmacińska B, Glice M.

J Pharm Biomed Anal. 2010 Dec 1;53(4):1033-6. doi: 10.1016/j.jpba.2010.06.018. Epub 2010 Jun 25.

PMID:
20655682
9.

Identification and characterization of potential impurities of quetiapine fumarate.

Stolarczyk EU, Kaczmarek L, Eksanow K, Kubiszewski M, Glice M, Kutner A.

Pharm Dev Technol. 2009;14(1):27-37. doi: 10.1080/10837450802409388.

PMID:
18815940
10.

[Distribution of latencies of visual evoked potentials in a sample of schizophrenic patients].

Małyszczak K, Kubiszewski M, Pilecki W, Maciejowski A, Sobieszczańska M.

Psychiatr Pol. 2003 Nov-Dec;37(6):989-97. Polish.

PMID:
14727371

Supplemental Content

Loading ...
Support Center